Retrospective Study
Copyright ©The Author(s) 2025.
World J Hepatol. May 27, 2025; 17(5): 106892
Published online May 27, 2025. doi: 10.4254/wjh.v17.i5.106892
Table 1 Baseline clinical characteristics, n (%)
Variables
cTIPS (n = 135)
iTIPS (n = 66)
P value
Age (years), mean ± SD58 ± 1156 ± 100.39
Sex (male)77 (57)41 (62)0.54
Ethnicity--< 0.0001
Non-Hispanic White113 (84)37 (56)-
Hispanic/Latino7 (5)25 (38)-
African American7 (5)0 (0)-
Asian8 (6)4 (6)-
TIPS indication--0.87
Variceal bleeding33 (24)19 (29)-
Refractory ascites81 (60)38 (58)-
Hepatic hydrothorax12 (9)6 (9)-
Other9 (7)3 (4)-
MELD-Na, mean ± SD17 ± 1416 ± 50.25
Etiology of liver disease--0.003
HBV/HCV26 (19)26 (39)-
Alcohol38 (28)22 (33)-
NASH36 (27)10 (15)-
Other35 (26)8 (12)-
PSG Pre-TIPS (mmHg), mean ± SD18 ± 618 ± 40.29
PSG Post-TIPS (mmHg), mean ± SD7 ± 36 ± 20.13
Final stent diameter (mm)--0.004
61 (1)2 (3)-
70 (0)2 (3)-
883 (61)51 (77)-
96 (4)3 (5)-
1040 (30)8 (12)-
Not documented5 (4)0 (0)-
Table 2 Post-procedure laboratory marker adverse events at one month, n (%)
Laboratory marker CTCAE grade1
cTIPS
iTIPS
P value
AST2n = 109n = 520.08
074 (68)44 (85)-
133 (30)8 (15)-
21 (1)0 (0)-
30 (0)0 (0)-
41 (1)0 (0)-
ALT3n = 109n = 530.18
0102 (94)53 (100)-
16 (5)0 (0)-
20 (0)0 (0)-
31 (1)0 (0)-
40 (0)0 (0)-
Total bilirubin4n = 109n = 530.82
037 (34)19 (36)-
137 (34)14 (26)-
224 (22)14 (26)-
310 (9)5 (9)-
41 (1)1 (2)-
INRn = 109n = 531
< 2 × BL109 (100)53 (100)-
> 2 × BL0 (0)0 (0)-